Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Syrian conflict drags hedge funds earning in August, HFRI Fund Weighted Composite Index -0.73% (3.87% YTD)

Tuesday, September 10, 2013

amb
Kenneth Heinz
Precy Dumlao, Opalesque Asia:

The ongoing civil war in Syria and the uncertain military action by the U.S. and its allies, the weakness in emerging market equities and currencies, expectations of a US QE tapering and a decline in the US equity markets dragged hedge funds' earnings in August, said data provider Hedge Funds Research (HFR).

August is the second negative month for HFRI indices this year. The HFRI Fund Weighted Composite Index fell -0.73% in August, bringing the year to date result to 3.87%, said HFR in a release yesterday.

"Volatility and uncertainty increased in August across both economic and political forums, contributing to mixed sub-strategy performance, wide dispersion and Macro-centric weakness across hedge fund strategy performance," stated Kenneth J. Heinz, President of HFR.

"While the geopolitical environment has remained fluid and unpredictable through month end, many funds entered August with conservat......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its